Autolus Therapeutics (AUTL) Other financing activities (2020 - 2024)
Autolus Therapeutics (AUTL) posted quarterly Other financing activities of $7000.0 for Q4 2024, down 69.57% year-on-year from $23000.0 in Q1 2024, and down 96.22% on a QoQ basis from $185000.0 in Q3 2024.
Autolus Therapeutics (AUTL) Other financing activities (2020 - 2024) Analysis & Trends
Autolus Therapeutics (AUTL) has reported Other financing activities for 5 consecutive years, with $7000.0 the latest figure, recorded in Q4 2024.
- Quarterly Other financing activities fell 69.57% year-over-year to $7000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $7000.0 (down 98.87% YoY) and the FY2024 annual result came in at $602000.0, up 2129.63% from the prior year.
- Other financing activities eased to $7000.0 in Q4 2024 per AUTL's latest filing, from $185000.0 in the prior quarter.
- Over the last five years, Other financing activities for AUTL reached as high as $391000.0 in Q4 2020 and fell as low as -$1000.0 in Q4 2021.
- A 5-year average of $126200.0 and a median of $121000.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2021 — Other financing activities slumped 100.26% — and 2024, when it soared 4525.0%.
- Year by year, Other financing activities stood at $391000.0 in 2020, then sank by 100.26% to -$1000.0 in 2021, then soared by 11800.0% to $117000.0 in 2022, then slumped by 80.34% to $23000.0 in 2023, then plunged by 69.57% to $7000.0 in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered $7000.0, $185000.0, and $125000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Autolus Therapeutics | 404.53 Mn | 103.82 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Sep 30, 2024 | 185,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 125,000.00 |
| Mar 31, 2024 | 285,000.00 |
| Mar 31, 2024 | 285,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2022 | 117,000.00 |
| Sep 30, 2022 | 117,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 126,000.00 |
| Sep 30, 2021 | 126,000.00 |
| Dec 31, 2020 | 391,000.00 |
| Dec 31, 2020 | 391,000.00 |